Search results
Breast cancer: New blood test can predict return, researchers say
BBC News· 1 day agoAn "ultra-sensitive" new blood test can predict if breast cancer will return years before the...
Breast cancer: Excessive weight gain occurs in 20% of survivors
Medical News Today· 15 hours agoResearchers are reporting that almost one in five breast cancer survivors experience weight gain of...
Test to detect if breast cancer will return ‘100 per cent accurate’
The Telegraph via Yahoo News· 2 days ago“Catching breast cancer recurrence earlier means treatment is much more likely to destroy the cancer...
Carefully Designing De-escalation Trials in Breast Cancer
Medscape· 5 days agoDe-escalation trials in early breast cancer are "critical to preserving quality of life" but require...
New blood test 'can predict' breast cancer return much before scans
Investing.com· 2 days agoLondon, June 2 (IANS) In a step that can ensure earlier detection and treatment of breast cancer and...
Targeting 'monster cancer cells' could reduce recurrence rates after cancer therapy
Medical Xpress· 6 days agoBoth types of therapy put cancer cells under stress, with the goal of causing them to self-destruct. Recently, scientists have begun to look at the role of polyploid giant ...
Exact Sciences (EXAS) to Showcase Favorable Research Outcome
Zacks via Yahoo Finance· 6 days agoExact Sciences' (EXAS) latest study research result shows commitment to innovation and strategies...
Lack of insurance may prevent Americans from accessing best cancer drugs
UPI· 9 hours agoAmong patients diagnosed with advanced melanomas, those who had private health insurance saw rates...
Neoadjuvant immunotherapy for early stage melanoma shows positive results
Medical Xpress· 9 hours agoThe NADINA study, led by researchers from the Netherlands Cancer Institute, was named one of the...
Pharma Stock Roundup: JNJ, MRK M&A Deals, SNY, RHHBY Drugs' Priority Review & More
Zacks· 4 days agoThe FDA granted priority review designations to Sanofi's (SNY Quick QuoteSNY - Free Report) and Roche’s (RHHBY Quick QuoteRHHBY - Free Report) regulatory applications seeking expanded use of ...